Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Hepatocelični rak - možnost resekcije jeter
Authors:ID Ivanecz, Arpad (Author)
ID Sremec, Marko (Author)
ID Jagrič, Tomaž (Author)
ID Potrč, Stojan (Author)
Files:.pdf PDF - Presentation file, download (520,99 KB)
MD5: ED7B4F2D1F8AA6D7F18EB609368F65DB
 
URL URL - Presentation file, visit http://www.dlib.si/details/URN:NBN:SI:doc-EKWUJWIK
 
Language:Slovenian
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Resekcija jeter (RJ) je ostala glavna oblika terapije pri solitarnem hepatoceličnem raku (HCC), pri bolnikih z ohranjeno funkcijsko rezervo jeter in v primernem splošnem stanju. Izpopolnjene slikovne preiskave so pripomogle k boljši izbiri bolnikov. Kirurgija jeter je napredovala: uporabne so številne tehnike transekcije jetrnega tkiva; dosegljive so različne naprave, ki omogočajo hitrejše in natančnejše operiranje v brezkrvnem operativnem polju. Izboljšana kirurška tehnika, vzdrževanje nizkega centralnega venskega pritiska in napredek pri negi bolnika po operaciji so omogočili, da se je smrtnost po operaciji jeter v izbranih serijah znižala celo do 0%. Barcelona Clinic Liver Cancer (BCLC) klasifikacija poleg zamejitve bolezni, nudi priporočila tudi glede izbora terapije. Kirurško terapijo omejuje zgolj na bolnike z zgodnjim stadijem raka. Namen tega prispevka je raziskati, ali je v sedanjem času mogoče RJ opraviti s sprejemljivimi kratko- in dolgoročnimi rezultati tudi pri bolnikih s takšnim HCC, pri katerem so prisotni številni in veliki tumorji, ki makroskopsko vdirajo v žile.
Keywords:jetra, hepatocelični rak, resekcija, kirurški postopki, operativni, zapleti, smrtnost, preživetje
Publication status:Published
Publication version:Version of Record
Publisher:Onkološki inštitut Ljubljana
Year of publishing:2014
Number of pages:str. 92-96, 118
Numbering:Leto 18, št. 2
PID:20.500.12556/DiRROS-12884 New window
UDC:616.36-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-EKWUJWIK
COBISS.SI-ID:5286463 New window
Note:Soavtorji: Marko Sremec, Tomaž Jagrič, Stojan Potrč;
Publication date in DiRROS:08.12.2020
Views:1308
Downloads:622
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija. strokovni časopis za zdravnike
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.12.2014

Secondary language

Language:English
Abstract:Liver resection (LR) has remained the main form of therapy for solitary hepatocellular cancer (HCC) in patients with preserved functional liver reserves and in good general condition. Advanced imaging has contributed to a better selection of patients. Liver surgery has advanced as there are many techniques of liver tissue transection useful and different instruments are available, which enable faster and more accurate surgery in the bloodless operating field. Improved surgical technique, maintenance of low central venous pressure and advancement in patient postoperative care have provided that mortality rates after liver surgery in selected series lowered as far as to 0%. The Barcelona Clinic Liver Cancer (BCLC) classification apart from disease control also offers recommendations with regard to therapy selection. It limits surgical therapy only to patients with early stage liver cancer. The purpose of this article is to research whether at present time it is perhaps better to perform radioiodine therapy with acceptable short- and long-term results even in patients with HCC, where there are numerous and large tumours present, macroscopically invading the veins.


Archive

niGradiv

Back